Pfizer News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Trading-Depot	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Trading-Depot

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

14.01.20	Genome & Co. In Clinical Trial And Supply Deal With Merck KGaA, Pfizer (RTTNews)
13.01.20	Biogen To Acquire Clinical Stage PF-05251749 From Pfizer - Quick Facts (RTTNews)
13.01.20	Axsome In Exclusive U.S. License Deal With Pfizer For Reboxetine - Quick Facts (RTTNews)
09.01.20	Pfizer Joins With EFFECTOR To Develop Therapy For Treatment-refractory Cancers (RTTNews)
07.01.20	Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)
06.01.20	Pfizer : Bavencio Improves OS In Patients With Metastatic Urothelial Carcinoma (RTTNews)
23.12.19	GSK Says ViiV Healthcare Gets CRL From FDA For Cabotegravir And Rilpivirine (RTTNews)
20.12.19	FDA Nod For BHC, Third Rituxan Biosim In The Offing, CBIO Soars, NERV Depressed (RTTNews)
18.12.19	Pfizer and Mylan Announce Two Future Viatris Board Members (Businesswire)
17.12.19	Pfizer Invites Public to View and Listen to Webcast of January 28 Conference Call with Analysts (Businesswire)
17.12.19	AXSM Again Proves It Is Awesome, MIRM Leaps To $22, WVE Doesn't Go The Distance (RTTNews)
17.12.19	XTANDI® (enzalutamide) Approved by U.S. FDA for the Treatment of Metastatic Castration-Sensitive Prostate Cancer (Businesswire)
16.12.19	Pfizer Declares First-Quarter 2020 Dividend and Announces Upcoming Investor Day to Highlight Strength of Innovative R&D Pipeline (Businesswire)
14.12.19	Are These Biotech Companies Buyout Candidates? Deal Or No Deal? (RTTNews)
13.12.19	Pfizer: CHMP Adopts Positive Opinion On VYNDAQEL - Quick Facts (RTTNews)
13.12.19	Pfizer Receives Positive CHMP Opinion for VYNDAQEL® for Use in Patients with Transthyretin Amyloid Cardiomyopathy, a Rare and Fatal Disease (Businesswire)
13.12.19	First Generic Version Of NuvaRing Gets FDA Nod, ONCT On Watch, SRPT Surges (RTTNews)
05.12.19	ViiV Healthcare Submits NDA To FDA For Fostemsavir On HIV-1 Infection (RTTNews)
02.12.19	Biotech Stocks Facing FDA Decision In December 2019 (RTTNews)
27.11.19	Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)
20.11.19	Biosimilar Race: U.S. Lags Behind Europe (RTTNews)
19.11.19	KRTX Makes Giant Leap, The Medicines' Working Well, AGRX On The Move (RTTNews)
18.11.19	FDA Approves Pfizer's ABRILADA, Fifth Biosimilar To Humira (RTTNews)
18.11.19	Pfizer: FDA Approves ABRILADA As Biosimilar To Humira - Quick Facts (RTTNews)
18.11.19	FDA Approves Pfizer’s Biosimilar, ABRILADA™ (adalimumab-afzb) for Multiple Inflammatory Conditions (Businesswire)
15.11.19	Bristol-Myers Squibb and Pfizer Announce Randomized, Controlled Trial to Evaluate the Effect of Atrial Fibrillation Screening on Health Outcomes in Older Individuals (Businesswire)
12.11.19	Mylan and Pfizer Announce Viatris as the New Company Name in the Planned Mylan-Upjohn Combination (Businesswire)
29.10.19	Pfizer Q3 Profit Rises; Lifts 2019 Profit View (RTTNews)
29.10.19	Pfizer Inc. Q3 adjusted earnings Beat Estimates (RTTNews)
29.10.19	PFIZER REPORTS THIRD-QUARTER 2019 RESULTS (Businesswire)
28.10.19	Biotech Stocks Facing FDA Decision In November 2019 (RTTNews)
14.10.19	ImaginAb, AstraZeneca, Pfizer, Takeda Join To Develop CD8 ImmunoPET Technology (RTTNews)
12.10.19	Pfizer Presents Positive Phase 3 Data at the 28th Congress of the European Academy of Dermatology and Venereology for Abrocitinib in Moderate to Severe Atopic Dermatitis (Businesswire)
30.09.19	Pfizer: Interim BEACON CRC Data Shows Encouraging Potential For BRAFTOVI Triplet (RTTNews)
27.09.19	Pfizer Inc. Awards "Golden Tickets” to Neutrolis and Mediar Therapeutics (Businesswire)
27.09.19	Pfizer Names CEO Albert Bourla To Succeed Ian Read As Chairman - Quick Facts (RTTNews)
27.09.19	Ian Read to Retire as Executive Chairman of Pfizer’s Board of Directors; Chief Executive Officer Dr. Albert Bourla Named Chairman (Businesswire)
27.09.19	Pfizer Announces Positive Top-Line Results On Abrocitinib (RTTNews)
24.09.19	Pfizer Declares Fourth-Quarter 2019 Dividend (Businesswire)
24.09.19	Pfizer Presents New Evidence of IBRANCE® (palbociclib) Effectiveness in HR+, HER2- Metastatic Breast Cancer Patients in Four Real-World Studies at ESMO Congress 2019 (Businesswire)
19.09.19	Pfizer Presents Scientific Advancements in Cancer Care at the ESMO Congress 2019 Highlighting Expanded Portfolio (Businesswire)
17.09.19	Pfizer Invites Public to View and Listen to Webcast of October 29 Conference Call With Analysts (Businesswire)
09.09.19	Pfizer Reports Positive Results From Phase 2 Study Of 20vPnC Vaccine Candidate (RTTNews)
03.09.19	Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)
22.08.19	Pfizer To Invest $500 Mln In Gene Therapy Manufacturing Plant (RTTNews)
21.08.19	U.S. FDA Grants XTANDI® (enzalutamide) Application Priority Review for the Treatment of Men with Metastatic Hormone-Sensitive Prostate Cancer (Businesswire)
21.08.19	Pfizer Invests Half Billion Dollars to Advance State-of-the-Art Gene Therapy Facility in Sanford, North Carolina (Businesswire)
16.08.19	Pfizer Recalls Migraine Tablets Over Concerns Of Bacterial Infection (RTTNews)
03.08.19	Pfizer Announces Phase 3 Top-Line Results for Rivipansel in Patients with Sickle Cell Disease Experiencing a Vaso-Occlusive Crisis (Businesswire)
01.08.19	AMRN'S Vascepa Hits Record Sales, ADMP Slumps On Stock Offering, SRDX On Watch… (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

28.04.25		Ausblick: Pfizer legt Quartalsergebnis vor
28.04.25		Ausblick: Novartis mit Zahlen zum abgelaufenen Quartal
28.04.25		Merck-Aktie in Grün: Milliardenschwere Übernahme von Springworks
28.04.25		Novartis-Aktie dennoch freundlich: Goldman Sachs-Analyst sieht Risiken wegen Dollar-Anteil an Umsätzen
28.04.25		Merck-Aktie: Jüngste Einstufung durch Goldman Sachs Group Inc.
28.04.25		Investment-Note für Merck-Aktie: Neue Analyse von Bernstein Research
28.04.25		Merck-Aktie erhält von JP Morgan Chase & Co. Bewertung: Overweight
28.04.25		DAX 40-Titel Bayer-Aktie: Diese Dividendenzahlung können Bayer-Aktionäre erwarten

28.04.25

Ausblick: Pfizer legt Quartalsergebnis vor

28.04.25

Ausblick: Novartis mit Zahlen zum abgelaufenen Quartal

28.04.25

Merck-Aktie in Grün: Milliardenschwere Übernahme von Springworks

28.04.25

Novartis-Aktie dennoch freundlich: Goldman Sachs-Analyst sieht Risiken wegen Dollar-Anteil an Umsätzen

28.04.25

Merck-Aktie: Jüngste Einstufung durch Goldman Sachs Group Inc.

28.04.25

Investment-Note für Merck-Aktie: Neue Analyse von Bernstein Research

28.04.25

Merck-Aktie erhält von JP Morgan Chase & Co. Bewertung: Overweight

28.04.25

DAX 40-Titel Bayer-Aktie: Diese Dividendenzahlung können Bayer-Aktionäre erwarten

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Roche Hldg G	265.10	1.22 %	K V
Lonza Grp	580.60	1.19 %	K V
Nestle	86.75	1.18 %	K V
Geberit	562.80	1.11 %	K V
Swiss Life Hldg	811.00	1.05 %	K V
Sonova Hldg	251.10	0.08 %	K V
Swiss Re	144.85	0.03 %	K V
Zurich Insur Gr	568.80	0.00 %	K V
Givaudan	3’870.00	-0.13 %	K V
Part Grp Hldg	1’091.50	-0.64 %	K V

Pfizer Aktie VALOR 962004 / ISIN US7170811035

Nachrichten zu Pfizer Inc.

Aktien Top/Flop

Pfizer Peer Group Nachrichten

Meistgelesene Nachrichten